Studying Warmed Lidocaine for Increased Analgesic Effect During Intravitreal Injections

NCT ID: NCT06962709

Last Updated: 2025-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-12

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigating whether warmed lidocaine increases analgesic effect for intravitreal injections

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Intensity Assessment Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving warmed lidocaine

Patients receive lidocaine jelly that has been warmed before they receive an intravitreal injection.

Group Type EXPERIMENTAL

Warmed lidocaine

Intervention Type OTHER

Lidocaine warmed to 98 F

Patients receiving room temperature lidocaine

Patients receive room temperature lidocaine before intravitreal injection

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Warmed lidocaine

Lidocaine warmed to 98 F

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Receiving intravitreal injection for any indication

Exclusion Criteria

* Previous participant in study
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Balaji

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Balaji

Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital - Mason Eye Clinic

Columbia, Missouri, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2090898

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cooling Anesthesia for Intravitreal Injection
NCT03732287 COMPLETED PHASE1/PHASE2
Cryoanesthesia for Intravitreal Injections
NCT02872012 COMPLETED PHASE1/PHASE2
PK and DPK of Lidocaine Dermal Products
NCT03145207 COMPLETED EARLY_PHASE1
Pain Perception: Lidocaine Rate/Temp/Buffer
NCT02823002 ACTIVE_NOT_RECRUITING NA